(Q36995248)

17 August 2017

1 reference

title

Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies (English)

1 reference

17 August 2017

1 reference

John W Wright

1

1 reference

17 August 2017

Shigehiko Mizutani

series ordinal

2

1 reference

17 August 2017

Joseph W Harding

series ordinal

3

1 reference

17 August 2017

publication date

7 November 2007

1 reference

17 August 2017

published in

Heart Failure Reviews

1 reference

17 August 2017

volume

13

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

367-375

1 reference

Vasoactive hormones induce nitric oxide synthase mRNA expression and nitric oxide production in human endothelial cells and monocytes

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

The design, structure, and therapeutic application of matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Management of heart failure in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Medication adherence in persons with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9060-Z

Extracellular matrix remodelling: the role of matrix metalloproteinases

21 January 2018

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

1 reference

12 December 2020

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

1 reference

12 December 2020

A canine model of chronic heart failure produced by multiple sequential coronary microembolizations

1 reference

12 December 2020

From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease

1 reference

12 December 2020

Role of the renin-angiotensin system in vascular diseases: expanding the field.

1 reference

12 December 2020

Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly

1 reference

12 December 2020

More evidence on blocking the renin–angiotensin–aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2)

1 reference

12 December 2020

Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell

1 reference

12 December 2020

Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly

1 reference

12 December 2020

Effect of age on plasma aldosterone response to exogenous angiotensin II in normotensive subjects

1 reference

12 December 2020

Losartan: a review of its use, with special focus on elderly patients

1 reference

12 December 2020

Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

12 December 2020

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

12 December 2020

Localization of angiotensin converting enzyme in rat heart

1 reference

12 December 2020

1 reference

12 December 2020

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

12 December 2020

Rethinking the renin-angiotensin system and its role in cardiovascular regulation.

1 reference

12 December 2020

Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure

1 reference

12 December 2020

Changes in the renin-angiotensin-aldosterone axis in later life

1 reference

12 December 2020

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

12 December 2020

Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy

1 reference

12 December 2020

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

1 reference

12 December 2020

1 reference

12 December 2020

The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory

1 reference

12 December 2020

Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations

1 reference

12 December 2020

Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats

1 reference

12 December 2020

Review: Potential of renin inhibition in cardiovascular disease

1 reference

12 December 2020

Synchronization and integration of multiple hypertrophic pathways in the heart

1 reference

12 December 2020

Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.

1 reference

12 December 2020

The role of the renin-angiotensin-aldosterone system in heart failure

1 reference

12 December 2020

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

1 reference

12 December 2020

Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor

1 reference

12 December 2020

Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation

1 reference

12 December 2020

Biochemistry and pharmacology of the renin-angiotensin system

1 reference

12 December 2020

Cellular distribution of angiotensin-converting enzyme after myocardial infarction

1 reference

12 December 2020

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

12 December 2020

Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases

1 reference

12 December 2020

Telmisartan: a review of its use in hypertension

1 reference

12 December 2020

G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor

1 reference

12 December 2020

Treatment of heart failure with abnormal left ventricular systolic function in the elderly

1 reference

12 December 2020

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension

1 reference

12 December 2020

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

12 December 2020

Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system

1 reference

12 December 2020

The cardiovascular continuum and renin-angiotensin-aldosterone system blockade

1 reference

12 December 2020

Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement

1 reference

12 December 2020

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

12 December 2020

The role of the renin-angiotensin system in the development of cardiovascular disease

1 reference

12 December 2020

Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway

1 reference

12 December 2020

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

1 reference

12 December 2020

Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade

1 reference

12 December 2020

Neural recognition molecules and synaptic plasticity

1 reference

12 December 2020

The effect of age on vascular compliance in man: which are the appropriate measures?

1 reference

12 December 2020

Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence

1 reference

12 December 2020

Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure

1 reference

12 December 2020

Orthostatic fall in blood pressure in the very elderly hypertensive: results from the hypertension in the very elderly trial (HYVET) - pilot

1 reference

12 December 2020

Are psychosocial factors associated with the pathogenesis and consequences of cardiovascular disease in the elderly?

1 reference

12 December 2020

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

12 December 2020

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

1 reference

12 December 2020

1 reference

12 December 2020

Potential for antihypertensive treatment with an AT(1)-receptor blocker to reduce dementia in the elderly

1 reference

12 December 2020

Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

1 reference

12 December 2020

Neural cell adhesion molecules in activity-dependent development and synaptic plasticity

1 reference

12 December 2020

Salt-sensitive hypertension develops after short-term exposure to Angiotensin II

1 reference

12 December 2020

10.1007/S10741-007-9060-Z

Identifiers

DOI

1 reference

17 August 2017

1 reference